DICE

DICE Therapeutics (DICE)

DICE Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DICE

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/08/21	21:00	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/11	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22:47	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22:45	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22:42	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22:38	Edgar (US Regulatory)	Form POSASR - Post-effective Amendment to an automatic shelf registration statement	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22:32	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22:20	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22:02	PR Newswire (US)	Lilly Completes Acquisition of DICE Therapeutics	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	05:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DICE	DICE Therapeutics Inc
2023/07/25	20:11	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
2023/07/25	19:55	PR Newswire (US)	Lilly Announces Extension of Tender Offer to Acquire DICE	NASDAQ:DICE	DICE Therapeutics Inc
2023/07/18	06:23	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
2023/07/01	05:22	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/24	06:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/24	06:11	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/23	05:33	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/22	06:01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/21	05:07	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/20	23:15	Dow Jones News	Trending: Eli Lilly Buys DICE Therapeutics in Deal Worth $2.4 Billion	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/20	21:21	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/20	20:42	Dow Jones News	Eli Lilly to Acquire DICE Therapeutics for $2.4 Billion	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/20	20:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DICE	DICE Therapeutics Inc